Zogenix to Participate in Cantor Fitzgerald Healthcare Conference

SAN DIEGO, July 6, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing and commercializing unique therapies for the treatment of central nervous system (CNS) disorders, today announced that Stephen J. Farr, Ph.D., President and CEO, will present a corporate update at the Cantor Fitzgerald Healthcare Conference in New York, NY, on July 8, 2015.

Cantor Fitzgerald Healthcare Conference

The presentation will be webcast live and archived for 30 days on Zogenix's Investor Relations website at ir.zogenix.com.

About Zogenix

Zogenix, Inc. (Nasdaq: ZGNX) is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.

For more information, visit www.zogenix.com.

CONTACT: Investors: Andrew McDonald
         Founding Partner, LifeSci Advisors LLC
         646-597-6987 | [email protected]

         Media: Catherine O'Connor
         Sr. Director, Corporate Communications, Zogenix
         858.436.3374 | [email protected]

You May Also Be Interested In

• Rubrik Inc (RBRK) PT Raised to $120 at Cantor Fitzgerald Into Q2 Earnings
• Dimensional Fund Advisors Ltd. : Form 8.3 - Irish Continental Group Plc - Ordinary Shares
• Dimensional Fund Advisors Ltd. : Form 8.3 - PROLOGIS INC - Ordinary Shares